Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Zimmer Biomet Holdings Inc (ZBH.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-03-04	120.44	117.385	Neutral
2022-04-08	129.62	-	No Rating
2023-03-28	126.14	112.00	Sell
2023-05-03	139.62	116.00	Sell
2023-08-01	132.27	125.00	Sell
2023-10-16	105.05	100.00	Sell
2023-11-07	105.93	99.00	Sell
2024-01-21	123.36	105.00	Sell
2024-02-08	123.04	109.00	Sell
2024-05-02	118.46	112.00	Sell
2024-08-08	108.70	107.00	Sell
2025-01-06	103.56	105.00	Sell
2025-05-05	90.48	91.00	Sell

Disclosures

UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and investment banking services are being, or have been, provided.
UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.